Ethacrynic acid

依他尼酸

Report date: 2023/01/13 20:00:32
NME

Base Information

Drug NameEthacrynic acid
Drug Alias NameEtacrynic Acidacidum etacrynicumEdecrinTekronHydromedin +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium-(potassium)-chloride cotransporter 2 inhibitors
TargetsSodium-(potassium)-chloride cotransporter 2
Therapy Area/IndicationsEdemaAscitesHeart Defects, Congenital +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesValeant
China Registration ClassN/A

Develop Information

Active CompaniesEql Pharma AbBausch & Lomb (Singapore) Pvi Ltd
Inactive CompaniesThe University Of Kansas Medical Center
Active IndicationsEdemaAscitesHeart Defects, Congenital +[4] 
Inactive IndicationsUrinary Bladder Neoplasms

Other Information

ATC CodeC03CC01
Related LinksWikipediaDrugBankKEGG